Bolton LP’s ResMed RMD Stock Holding History

Bolton LP’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-56,200	Closed	-$2.97M	–	311
2013 Q3	$2.97M	Buy	+56,200	New	+$2.73M	0.81%	28

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Bolton LP's RMD Position: Q4 2013 in Review

Bolton LP sold out of ResMed (RMD) in Q4 2013, closing a stake of 56,200 shares — an estimated $2.97M sold.

Bolton LP first reported a position in RMD in Q3 2013 and held it in 1 quarter. The position peaked at $2.97M in Q3 2013. 328 funds tracked by Wall St. Rank hold RMD as of Q4 2013.

Bolton LP reported no remaining ResMed position as of Q4 2013 after selling out during the quarter.
Bolton LP sold 56,200 ResMed shares in Q4 2013, an estimated $2.97M.
Bolton LP first reported a position in ResMed in Q3 2013 and held it in 1 quarter.
Bolton LP's ResMed position peaked at $2.97M in Q3 2013.
328 funds tracked by Wall St. Rank held ResMed as of Q4 2013.

Based on Bolton LP's 13F filing for Q4 2013, filed 13 Feb 2014.